49 results on '"Sobieski, Mary"'
Search Results
2. Epichaperome inhibition targets TP53-mutant AML and AML stem/progenitor cells
3. Combined inhibition of HMGCoA reductase and mitochondrial complex I induces tumor regression of BRAF inhibitor-resistant melanomas
4. EphA2- and HDAC-Targeted Combination Therapy in Endometrial Cancer
5. Author Correction: Exploring the advantages of intensity-modulated proton therapy: experimental validation of biological effects using two different beam intensity-modulation patterns
6. Exploring the advantages of intensity-modulated proton therapy: experimental validation of biological effects using two different beam intensity-modulation patterns
7. GSK3β regulates epithelial-mesenchymal transition and cancer stem cell properties in triple-negative breast cancer
8. Abstract 453: Targeting FOXL2C402Gvulnerabilities in adult type ovarian granulosa cell tumors
9. Supplementary Data from Rational Combination of CRM1 Inhibitor Selinexor and Olaparib Shows Synergy in Ovarian Cancer Cell Lines and Mouse Models
10. Combining MEK and SRC inhibitors for treatment of colorectal cancer demonstrate increased efficacy in vitro but not in vivo
11. Abstract P6-10-19: Screening of GPCR-targeting drugs for repositioning in breast cancer
12. Combination of EphA2- and Wee1-Targeted Therapies in Endometrial Cancer
13. Screening of GPCR drugs for repurposing in breast cancer
14. A High Content Clonogenic Survival Drug Screen Identifies MEK Inhibitors as Potent Radiation Sensitizers for KRAS Mutant Non–Small-Cell Lung Cancer
15. Agents That Stabilize Mutated von Hippel–Lindau (VHL) Protein: Results of a High-Throughput Screen to Identify Compounds That Modulate VHL Proteostasis
16. Additional file 1 of Combined inhibition of HMGCoA reductase and mitochondrial complex I induces tumor regression of BRAF inhibitor-resistant melanomas
17. Additional file 2 of Combined inhibition of HMGCoA reductase and mitochondrial complex I induces tumor regression of BRAF inhibitor-resistant melanomas
18. Additional file 3 of Combined inhibition of HMGCoA reductase and mitochondrial complex I induces tumor regression of BRAF inhibitor-resistant melanomas
19. Rational Combination of CRM1 Inhibitor Selinexor and Olaparib Shows Synergy in Ovarian Cancer Cell Lines and Mouse Models
20. Abstract P256: Pan-ErbB inhibition enhances activity of KRASG12C inhibitors in preclinical models of KRASG12C mutant cancers
21. Targeting the Oncogenic Functions of an RNA-Binding Protein Involved in Hematologic Malignancies
22. Sequential Administration of XPO1 and ATR Inhibitors Enhances Therapeutic Response in TP53-mutated Colorectal Cancer
23. Abstract B20: Unbiased high-throughput screenings to identify combination therapies targeting RAS-mutated colorectal cancer
24. Additional file 8: of GSK3β regulates epithelial-mesenchymal transition and cancer stem cell properties in triple-negative breast cancer
25. Additional file 9: of GSK3β regulates epithelial-mesenchymal transition and cancer stem cell properties in triple-negative breast cancer
26. Additional file 10: of GSK3β regulates epithelial-mesenchymal transition and cancer stem cell properties in triple-negative breast cancer
27. Developing the Zebrafish Neuromast Assay as a Predictive Toxicity Model
28. Abstract 4669: Overcoming therapy resistance in stem cell-rich triple negative breast cancer through p38 MAP kinase inhibition
29. Abstract LB-320: PPTC testing of an OLIG2 inhibitor CT-179 in patient-derived orthotopic xenograft mouse models of pediatric GBM
30. HGG-01. RADIATION INCREASES PRE-CLINICAL EFFICACY OF OLIG2 INHIBITOR CT-179 IN PEDIATRIC GBM
31. Xenotransplantation of pediatric low grade gliomas confirms the enrichment of BRAF V600E mutation and preservation of CDKN2A deletion in a novel orthotopic xenograft mouse model of progressive pleomorphic xanthoastrocytoma
32. EXTH-08. NOVEL OLIG2 INHIBITOR DEMONSTRATES PRE-CLINICAL EFFICACY IN PEDIATRIC GBM
33. HG-18NOVEL OLIG2 INHIBITOR DEMONSTRATES PRE-CLINICAL EFFICACY IN PEDIATRIC GBM
34. Systematic high-throughput combination drug screen to enhance poly (ADP-ribose) polymerase (PARP) inhibitor efficacy in ovarian cancer.
35. Spatial mapping of the biologic effectiveness of scanned particle beams: towards biologically optimized particle therapy
36. Abstract 4898: High content clonogenic survival assay for drug library screening identifies potent radiation sensitizers for non-small cell lung cancer
37. Abstract B08: High-throughput synthetic lethal drug screen to identify novel radiation sensitizers for KRAS mutant non-small cell lung cancer
38. Results of a high-throughput screen to identify compounds that modulate VHL proteostasis.
39. Abstract 1379: High throughput screening to identify molecules that alter VHL stability
40. Additional file 3: of GSK3β regulates epithelial-mesenchymal transition and cancer stem cell properties in triple-negative breast cancer
41. Additional file 5: of GSK3β regulates epithelial-mesenchymal transition and cancer stem cell properties in triple-negative breast cancer
42. Additional file 4: of GSK3β regulates epithelial-mesenchymal transition and cancer stem cell properties in triple-negative breast cancer
43. Additional file 7: of GSK3β regulates epithelial-mesenchymal transition and cancer stem cell properties in triple-negative breast cancer
44. Additional file 2: of GSK3β regulates epithelial-mesenchymal transition and cancer stem cell properties in triple-negative breast cancer
45. Additional file 3: of GSK3β regulates epithelial-mesenchymal transition and cancer stem cell properties in triple-negative breast cancer
46. Additional file 5: of GSK3β regulates epithelial-mesenchymal transition and cancer stem cell properties in triple-negative breast cancer
47. Additional file 2: of GSK3β regulates epithelial-mesenchymal transition and cancer stem cell properties in triple-negative breast cancer
48. Additional file 7: of GSK3β regulates epithelial-mesenchymal transition and cancer stem cell properties in triple-negative breast cancer
49. Additional file 4: of GSK3β regulates epithelial-mesenchymal transition and cancer stem cell properties in triple-negative breast cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.